An AI deep learning model has shown better accuracy in predicting treatment margins and negative margin probabilities for resected prostate cancer specimens compared to conventional models, according to a study published in European Urology Open Science. The study developed a novel AI-driven approach and platform that combines multimodal information, such as MRI, tracked biopsy, and […]
